Workflow
Globenewswire
icon
Search documents
Interparfums, Inc. Reports Record 2025 Fourth Quarter and Full Year Results
Globenewswire· 2026-02-24 21:05
FY2025 Net Sales $1.49 Billion and Diluted EPS of $5.24 Per Share; Reaffirms FY2026 Guidance and Maintains Annual Cash Dividend of $3.20 for 2026 NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today reported record results for the fourth quarter and full year ended December 31, 2025. Financial Highlights:($ in millions, except per share amounts)Three Months EndedDecember 31,Year EndedDecember 31,20252024% Change20252024% Ch ...
MYR Group Inc. to Attend Jefferies Power, Energy, Clean Energy & Utilities Conference in March
Globenewswire· 2026-02-24 21:05
THORNTON, Colo., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced it will attend the Jefferies Power, Energy, Clean Energy & Utilities investor conference. MYR Group’s Chief Executive Officer, Rick Swartz; Chief Financial Officer, Kelly Huntington; and Vice President, Investor Relations and Trea ...
Aktis Oncology to Present at Upcoming March Investor Conferences
Globenewswire· 2026-02-24 21:05
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies, today announced that Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology, will present at the following investor conferences in March 2026. TD Cowen 46th Annual Health Care Conference Date & Time: T ...
Palvella Therapeutics Announces Proposed Public Offering
Globenewswire· 2026-02-24 21:05
WAYNE, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that it has commenced an underwritten public offering of $150.0 million of shares of its common stock. In addition, Palve ...
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
Globenewswire· 2026-02-24 21:05
- Blinded evaluation of safety and tolerability data by the Safety Monitoring Committee from Cohort 1 and advancement to Cohort 2 is expected in 3Q 2026 – - Advancement reflects continued execution of capital-efficient development strategy leveraging POZ Platform™ - HUNTSVILLE, AL, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing drug candidates enabled by its proprietary POZ Platform™ drug optimiz ...
CCC Intelligent Solutions Holdings Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results
Globenewswire· 2026-02-24 21:05
CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- CCC Intelligent Solutions Holdings Inc. (“CCC” or the “Company”) (NASDAQ: CCC), a leading SaaS platform provider for the multi-trillion-dollar insurance economy, today announced its financial results for the three months and year ended December 31, 2025. “CCC closed out 2025 with solid financial performance, delivering 12% year‑over‑year revenue growth and an adjusted EBITDA margin of 41% for full year 2025. We achieved these results while continuing to invest for ...
Navitas Semiconductor Announces Fourth Quarter and Full Year 2025 Financial Results
Globenewswire· 2026-02-24 21:05
Accelerating strategic pivot to Navitas 2.0 with focus on GaN and high-voltage SiC solutions targeting high growth, high-power markets (AI Data Centers, Grid and Energy Infrastructure, Performance Computing and Industrial Electrification) totaling $3.5 billion serviceable available market (SAM) in 2030High-power markets represented majority of quarterly revenue for the first time in the Company’s history with mobile declining to less than 25%Anticipates a return to top-line sequential growth beginning in t ...
Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share
Globenewswire· 2026-02-24 21:05
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “CGBD” or the “Company”) (NASDAQ: CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD’s Chief Executive Officer, said, “As CGBD’s newly appointed CEO, I look forward to continuing to build on Carlyle’s strong track record and world-class platform. Building off record origination volume in the fourth qua ...
Climb Global Solutions, Inc. Acquires interworks.cloud, Strengthening Cloud and Software Distribution Capabilities Across Europe
Globenewswire· 2026-02-24 21:05
Acquisition Expands Climb’s Reach in Greece, Malta, Bulgaria and Cyprus and Advances Pan-European Microsoft Distribution Strategy Transaction Expected to be Accretive to Earnings and Adjusted EBITDA EATONTOWN, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, has completed the acquisition of interworks.cloud (“Interworks”), ...
Rapid7 to Attend Raymond James 47th Annual Institutional Investors Conference
Globenewswire· 2026-02-24 21:05
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today announced that the company will be attending the Raymond James 47th Annual Institutional Investors Conference. The presentation is scheduled for Wednesday, March 4, 2026 at 11:35 a.m. Eastern Time. The presentation will be webcast live, and a replay will be available for a limited time, under the “Events and Presentations” section on the company’s investor relations web ...